Tacrolimus reduces urinary excretion of leukotriene E 4 and inhibits aspirin-induced asthma to threshold dose of aspirin

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 6, 2004, Pages 1278-1281

  Kawano, Tetsuya ^a   Matsuse, Hiroto ^a   Kondo, Yuki ^a   MacHida, Ikuko ^a   Saeki, Sachiko ^a   Tomari, Shinya ^a   Mitsuta, Kazuko ^a   Fukushima, Chizu ^a   Obase, Yasushi ^a   Shimoda, Terufumi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

11 dehydrothromboxane B 2; Aspirin induced asthma; eosinophilic cationic protein; leukotriene; tacrolimus

Indexed keywords

ACETYLSALICYLIC ACID; EOSINOPHIL CATIONIC PROTEIN; LEUKOTRIENE E4; PEPTIDOLEUKOTRIENE; TACROLIMUS;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MALE; PRIORITY JOURNAL; SPUTUM ANALYSIS; URINARY EXCRETION;

ADULT; ASPIRIN; ASTHMA; BRONCHOCONSTRICTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EOSINOPHIL CATIONIC PROTEIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOTRIENE E4; MALE; MIDDLE AGED; P-GLYCOPROTEINS; TACROLIMUS;

EID: 9644265248     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.09.003     Document Type: Article

References (34)

1. J. Jawien A new insight into aspirin-induced asthma Eur J Clin Invest 32 2002 134 138
2. C. Picado Aspirin-intolerant asthma: role of cyclooxygenase enzymes Allergy 57 suppl 72 2002 58 60
3. W.W. Busse, and R.F. Lemanske Asthma (review) N Engl J Med 344 2001 350 362
4. M. Larche, D.S. Robinson, and A.B. Kay The role of T lymphocytes in the pathogenesis of asthma J Allergy Clin Immunol 111 2003 450 464
5. J.M. Drazen, E. Israel, and P.M. O'Byrne Treatment of asthma with drugs modifying the leukotriene pathway N Engl J Med 340 1999 197 206
6. P.J. Barnes Molecular basis for corticosteroid action in asthma Chem Immunol 78 2000 72 80
7. N. Matsuo, T. Shimoda, K. Mitsuta, C. Fukushima, H. Matsuse, and Y. Obase Tacrolimus inhibits cytokine production and chemical mediator release following antigen stimulation of passively sensitized human lung tissues Ann Allergy Asthma Immunol 86 2001 671 678
8. M. Boguniewicz, L.F. Eichenfield, and T. Hultsch Current management of atopic dermatitis and interruption of the atopic march J Allergy Clin Immunol 112 2003 S140 S150
9. Y. Sasakawa, S. Sakuma, Y. Higashi, T. Sasakawa, T. Amaya, and T. Goto FK506 suppresses neutrophil chemoattractant production by peripheral blood mononuclear cells Eur J Pharmacol 403 2000 281 288
10. Fung JJ. Tacrolimus and transplantation: a decade in review. Transplantation 2004;15:77:s41-s43.
11. B.D. Kahan, and S.M. Koch Current immunosuppressant regimens: considerations for critical care Curr Opin Crit Care 7 2001 242 250
12. S.M. Cheer, and G.L. Plosker Tacrolimus ointment: a review of its therapeutic potential as a topical therapy in atopic dermatitis Am J Clin Dermatol 2 2001 389 406
13. A. Evoli, C. Di Schino, F. Marsili, and C. Punzi Successful treatment of myasthenia gravis with tacrolimus Muscle Nerve 25 2002 111 114
14. National Institutes of Health/National Heart, Lung, and Blood Institute. Global strategy for asthma management and prevention: a practical guide for public health officials and health care professionals. Bethesda (MD): National Institutes of Health; 1995.
15. Y. Obase, T. Shimoda, S. Tomari, K. Mitsuta, C. Fukushima, and T. Kawano Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirin-intolerant and tolerant asthmatic patients Ann Allergy Asthma Immunol 87 2001 74 79
16. Y. Obase, T. Shimoda, S.Y. Tomari, K. Mitsuta, T. Kawano, and H. Matsuse Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients Chest 121 2002 143 150
17. L.J. Scott, K. McKeage, S.J. Keam, and G.L. Plosker Tacrolimus: a further update of its use in the management of organ transplantation Drugs 63 2003 1247 1297
18. D. Przepiorka, R.A. Nash, J.R. Wingard, J. Zhu, R.M. Maher, and W.E. Fitzsimmons Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation Biol Blood Marrow Transplant 5 1999 94 97
19. M.L. Henry Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles Clin Transplant 13 1999 209 220
20. A. Szczeklik The cyclooxygenase theory of aspirin-induced asthma Eur Respir J 3 1990 588 593
21. A. de Paulis, R. Cirillo, A. Ciccarelli, G. de Crescenzo, A. Oriente, and G. Marone Characterization of the anti-inflammatory effect of FK-506 on human mast cells J Immunol 147 1991 4278 4285
22. W.R. Sperr, H. Agis, H. Semper, R. Valenta, M. Susani, and M. Sperr Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506 Int Arch Allergy Immunol 114 1997 68 73
23. A. Mori, M. Suko, Y. Nishizaki, O. Kaminuma, G. Matsuzaki, and K. Ito Regulation of interleukin-5 production by peripheral blood mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid Int Arch Allergy Immunol 104 suppl 1 1994 32 35
24. A. Wollenberg, S. Sharma, D. von Bubnoff, E. Geiger, J. Haberstok, and T. Bieber Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis J Allergy Clin Immunol 107 2001 445 448
25. G. Jedlitschky, and D. Keppler Transport of leukotriene C4 and structurally related conjugates Vitam Horm 64 2002 153 184
26. D. Keppler, G. Jedlitschky, and I. Leier Transport and metabolism of leukotrienes Adv Prostaglandin Thromboxane Leukot Res 22 1994 83 89
27. M. Bohme, G. Jedlitschky, I. Leier, M. Buchler, and D. Keppler ATP-dependent export pumps and their inhibition by cyclosporins Adv Enzyme Regul 34 1994 371 380
28. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J Natl Cancer Inst 16 2000 1295 1302
29. R. Nakano, M. Oka, T. Nakamura, M. Fukuda, S. Kawabata, and K. Terashi A leukotriene receptor antagonist, ONO-1078, modulates drug sensitivity and leukotriene C4 efflux in lung cancer cells expressing multidrug resistance protein Biochem Biophys Res Commun 251 1998 307 312
30. M. Kavallaris The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance Anticancer Drugs 8 1997 17 25
31. P. Grude, E. Boleslawski, F. Conti, S. Chouzenoux, and Y. Calmus MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation Transplantation 73 2002 1824 1828
32. G.A. Altenberg Structure of multidrug-resistance proteins of the ATP-binding cassette (ABC) superfamily Curr Med Chem Anticancer Agents 4 2004 53 62
33. M. Volm Multidrug resistance and its reversal Anticancer Res 18 1998 2905 2917
34. J. Wijnholds, R. Evers, M.R. van Leusden, C.A. Mol, G.J. Zaman, and U. Mayer Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein Nat Med 3 1997 1275 1279